Multiobjective optimization of fluphenazine nanocomposite formulation using NSGA-II method

The World Health Organization (WHO, 2019) reports that schizophrenia affects approximately 20 million people worldwide, and the annual number of new cases is estimated at 1.5%/10,000 people. As a result, there is a demand for making the relevant medicines work better. Using a fluphenazine (FZN) drug...

Full description

Bibliographic Details
Main Authors: Hussein-Al-Ali, S.H (Author), Ramadan, S.Z (Author), Sharar, A.A.A (Author)
Format: Article
Language:English
Published: Sciendo 2022
Subjects:
Online Access:View Fulltext in Publisher